This technique quantifies flutamide in pharmaceuticals, highlighting its role as a treatment for prostate cancer.
Background: A non-steroidal antiandrogen, flutamide (FA), has been used often to treat advanced prostate cancer. It blocks testosterone's tendency to bind to androgen receptors inside cells in some of the target organs, such as hair follicles, the prostate gland, skin, and testicles.
No takes yet. Share an insight, caveat, or question.
Chikkalingaiah et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: